News
QGEN
39.10
-1.73%
-0.69
Is Qiagen (QGEN) Undervalued Following Its Index Addition And QIAcuity Expansion?
Simply Wall St · 1d ago
Weekly Report: what happened at QGEN last week (0622-0626)?
Weekly Report · 2d ago
Qiagen (QGEN) Gets a Hold from Kepler Capital
TipRanks · 4d ago
QIAGEN reports supervisory board member’s vested share award under MAR rules
TipRanks · 5d ago
Is Qiagen's (QGEN) Digital PCR Expansion Quietly Redefining Its Competitive Moat in Biopharma Tools?
Simply Wall St · 6d ago
Qiagen initiated with a Hold at Kepler Cheuvreux
TipRanks · 6d ago
Barclays Sticks to Their Hold Rating for Qiagen (QGEN)
TipRanks · 06/24 08:25
DZ BANK AG Remains a Buy on Qiagen (QGEN)
TipRanks · 06/24 04:45
Goldman Sachs Discloses 3.07% Stake in Qiagen via Complex Instrument Mix
TipRanks · 06/23 21:14
Bank of America reports 2.95% stake in Qiagen via shares and swaps
TipRanks · 06/23 21:13
Goldman Sachs discloses 3.33% stake in Qiagen via AFM filing
TipRanks · 06/23 21:12
Goldman Sachs Discloses 3.28% Stake in Qiagen via Shares and Derivatives
TipRanks · 06/23 21:11
Qiagen Price Target Raised to $42.00/Share From $40.00 by Morgan Stanley
Dow Jones · 06/23 17:46
Qiagen Raised to Overweight From Equal-Weight by Morgan Stanley
Dow Jones · 06/23 17:46
Morgan Stanley Upgrades Qiagen to Overweight, Raises Price Target to $42
Benzinga · 06/23 17:36
IBM upgrade, SpaceX initiation among today’s top calls on Wall Street
TipRanks · 06/23 15:23
Positive Report for Qiagen (QGEN) from Morgan Stanley
TipRanks · 06/23 05:56
Weekly Report: what happened at QGEN last week (0615-0619)?
Weekly Report · 06/22 09:18
Qiagen (QGEN) Stock Could Be 15.7% Undervalued After QIAcuity Expansion
Simply Wall St · 06/21 15:17
Bank of America Reveals 3.01% Indirect Stake in Qiagen
TipRanks · 06/19 20:28
More
Webull provides a variety of real-time QGEN stock news. You can receive the latest news about Qiagen through multiple platforms. This information may help you make smarter investment decisions.
About QGEN
Qiagen NV is a holding company based in the Netherlands. The Company is engaged in providing Sample to Insight solutions that transform biological samples into molecular insights. Its Sample to Insight solutions integrate sample and assay technologies, bioinformatics and automation systems. Its sample technologies are used for isolating and preparing deoxyribonucleic acid (DNA), ribonucleic acid (RNA) and proteins from blood or other liquids, tissue, plants or other materials. Its assay technologies make these biomolecules visible for analysis, such as identifying the genetic information of a pathogen or a gene mutation in a tumor. Its bioinformatics solutions interpret data to provide actionable insights. The Company's automation platforms based on polymerase chain reaction (PCR), next-generation sequencing (NGS) and other technologies tie these together in molecular testing workflows from Sample to Insight.